WuXi AppTec

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• 直击药明康德股东会：打完业绩翻身仗，还剩哪些“未知数”？ (öffnet in neuem Tab)

  Moomoo · 01.10.2026

• Top China Biopharma Stocks to Watch, According to Bernstein (öffnet in neuem Tab)

  30.09.2026

• 
  Pharmaceutical Impurity Synthesis and Isolation Services Report: Capitalize on a $2.1 Billion Market by 2030 as Tariffs and 8.9% Isolation Growth Reshape Competition Across Eurofins, WuXi AppTec, Cambrex and Charles River (öffnet in neuem Tab)

  29.09.2026

• 药明康德(603259):无锡药明康德新药开发股份有限公司章程（2026年第二次修订） (öffnet in neuem Tab)

  中财网 · 29.09.2026

• 
  Contract Research Organization Services Market Forecasts Growth from $107.03B (2025) to $180.56B by 2030, Profiling IQVIA, Charles River, Syneos Health & WuXi AppTec (öffnet in neuem Tab)

  GlobeNewswire · 24.09.2026

• Secure the Global Drug Discovery Services Report: Capitalize on AI-driven outsourcing and benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Syngene before rivals capture the next revenue wave (öffnet in neuem Tab)

  24.09.2026

• Capitalize on Pharmacokinetics Outsourcing Disruption as Charles River, Labcorp, WuXi AppTec, Eurofins and Sygnature Compete to Dominate Drug Development ROI (öffnet in neuem Tab)

  23.09.2026

• Capitalize on the In Vivo Toxicology Shake-Up: Benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Thermo Fisher Before R&D Shifts Redraw Global Market Share (öffnet in neuem Tab)

  23.09.2026

• 
  Capitalize on the Drug Discovery Outsourcing Shift: Benchmark Charles River, WuXi AppTec, Evotec, Labcorp and Sygnature to Secure R&D ROI and Outsmart the Global Market (öffnet in neuem Tab)

  GlobeNewswire · 23.09.2026

• 
  Capitalize on the Toxicology Testing Services Market Shift: Benchmark Labcorp, Charles River, Eurofins, SGS and WuXi AppTec to Secure Growth and Outpace Disruption (öffnet in neuem Tab)

  GlobeNewswire · 23.09.2026

• 
  Recent Price Trend in Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) is Your Friend, Here's Why (öffnet in neuem Tab)

  Zacks · 22.09.2026

• Capitalize on the ADME-Toxicology Testing Shift: Benchmark Charles River, Thermo Fisher, Eurofins, WuXi AppTec and Evotec to Accelerate R&D ROI and Outpace Disruption (öffnet in neuem Tab)

  22.09.2026

• Long-Acting Oligonucleotide Development: Dosing, Yield and Stability Questions (öffnet in neuem Tab)

  10.09.2026

• Oligonucleotide Drug Delivery Is Moving Beyond the Liver (öffnet in neuem Tab)

  03.09.2026

• 
  WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion (öffnet in neuem Tab)

  PR Newswire · 31.08.2026

• 
  Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Is a Great Choice for 'Trend' Investors, Here's Why (öffnet in neuem Tab)

  Zacks · 27.08.2026

• Here's Why Momentum in Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Should Keep going (öffnet in neuem Tab)

  11.08.2026

• 
  Judge blocks US decision to add WuXi to list of firms tied to Chinese military (öffnet in neuem Tab)

  Reuters · 07.08.2026

• 
  WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model (öffnet in neuem Tab)

  PR Newswire · 03.08.2026

• 
  WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year (öffnet in neuem Tab)

  PR Newswire · 22.07.2026

• 
  China's WuXi sues US over allegations it supports Beijing's military (öffnet in neuem Tab)

  Reuters · 11.06.2026

• 
  WuXi AppTec hits back after being named in Pentagon’s Chinese military list (öffnet in neuem Tab)

  Pharmaceutical Technology · 09.06.2026

• 
  How The WuXi AppTec (SHSE:603259) Story Is Shifting With New Targets And Conviction Calls (öffnet in neuem Tab)

  Simply Wall St. · 29.04.2026